InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Canada

  • Welcome to the Canadian pharmaceutical patent dance

    Canada’s new drug and biosimilar patent linkage system will fundamentally change the nature of proceedings. J Bradley White and Nathaniel Lipkus of Osler Hoskin & Harcourt discuss key changes of interest to life sciences companies

  • Five important cases from Canada

    Michael Loney and Natalie Rahhal analyse five IP decisions issued in Canada, two from the Supreme Court and three from the Federal Court

  • Canada: The new frontier for global IP litigation

    The landscape for IP litigation has improved considerably in Canada. Kevin P Siu and Steven B Garland of Smart & Biggar outline the benefits for global rights owners


profile

Managing IP

ManagingIP

ManagingIP profile

John Bochnovic, Executive Director of AIPPI, has resigned from the position (effective April 30, 2018) to return to… https://t.co/4dp8lsqg5Z

Feb 16 2018 04:19 ·  reply ·  retweet ·  favourite
ManagingIP profile

CAFC says 101 inquiry is a factual determination in “blockbuster” Berkheimer opinion https://t.co/wpYscoUhnY https://t.co/FPrkImTmGL

Feb 16 2018 03:13 ·  reply ·  retweet ·  favourite
ManagingIP profile

US falls to 12th in US Chamber patent ranking https://t.co/UP7AvAbZ4k Expect to hear this figure mentioned a lot at… https://t.co/gnWLDdISl2

Feb 15 2018 04:45 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null null null

null null null

February 2018

FRAND aid: Is the European Commission’s SEP guidance useful?

Both patent owners and implementers have welcomed the European Commission’s communication on standard essential patents. Does that mean it has successfully balanced competing interests or merely dodged the difficult questions? James Nurton investigates



Most read articles

Supplements